Markets:

Overview

News

Currencies

International

Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

6.435 -0.125 (-1.91%)

Streaming Delayed Price Updated: 3:44 PM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday ↗

October 28, 2022

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...

Via Benzinga

Expert Ratings for Taysha Gene Therapies ↗

October 26, 2022

Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter:

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 27, 2022

Gainers

Via Benzinga

Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session ↗

October 27, 2022

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process...

Via Benzinga

US Stocks Mostly Higher; Dow Jumps Over 400 Points ↗

October 27, 2022

U.S. stocks traded mostly higher this morning, with the Dow Jones climbing more than 400 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 27, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Short Volatility Alert: Taysha Gene Therapies, Inc. ↗

October 26, 2022

On Tuesday, shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) experienced volatile short activity. After the activity, the stock price went up +97.35% to $2.98. The overall sentiment for TSHA has...

Via Benzinga

Nasdaq Dips 1.5%; Alphabet Misses Q3 Estimates ↗

October 26, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 1.5% on Wednesday.

Via Benzinga

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 26, 2022

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 26, 2022

It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!

Via InvestorPlace

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 25, 2022

Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.

Via Benzinga

Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings ↗

October 25, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 25, 2022

Gainers

Via Benzinga

S&P 500 Rises Over 1%; General Motors Earnings Top Views ↗

October 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday.

Via Benzinga

Analyzing Taysha Gene Therapies's Short Interest ↗

October 25, 2022

Taysha Gene Therapies's (NASDAQ:TSHA) short percent of float has fallen 5.27% since its last report. The company recently reported that it has 889 thousand shares sold short, which is 4.31% of all...

Via Benzinga

Why Is Xerox (XRX) Stock Down 20% Today? ↗

October 25, 2022

Xerox (XRX) stock is heading lower on Tuesday thanks to the release of its earnings report for the third quarter of 2022.

Via InvestorPlace

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics

October 25, 2022

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic

Via Spotlight Growth

What Is Going on With Taysha Gene (TSHA) Stock Today? ↗

October 25, 2022

Taysha and its new partner Astellas are both speculating that Adeno Associated Viruses can create treatments for genetic diseases.

Via InvestorPlace

Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs ↗

October 25, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 25, 2022

Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 25, 2022

We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!

Via InvestorPlace

Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket ↗

October 25, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene...

Via Benzinga

What 4 Analyst Ratings Have To Say About Taysha Gene Therapies ↗

August 12, 2022

Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗

August 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.